ResMed Financial Statements From 2010 to 2024

RMD Stock  USD 249.56  5.78  2.37%   
ResMed financial statements provide useful quarterly and yearly information to potential ResMed Inc investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on ResMed financial statements helps investors assess ResMed's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting ResMed's valuation are summarized below:
Gross Profit
2.4 B
Profit Margin
0.2315
Market Capitalization
35.8 B
Enterprise Value Revenue
7.532
Revenue
4.8 B
There are over one hundred nineteen available trending fundamental ratios for ResMed Inc, which can be analyzed over time and compared to other ratios. Investors should ensure to check out all of ResMed's recent performance against the performance from 2010 to 2024 to make sure the company is sustainable down the road. The current year's Market Cap is expected to grow to about 461.4 M. The current year's Enterprise Value is expected to grow to about 451 M

ResMed Total Revenue

4.92 Billion

Check ResMed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ResMed's main balance sheet or income statement drivers, such as Depreciation And Amortization of 227 M, Interest Expense of 48 M or Total Revenue of 4.9 B, as well as many indicators such as Price To Sales Ratio of 4.26, Dividend Yield of 0.0138 or PTB Ratio of 4.77. ResMed financial statements analysis is a perfect complement when working with ResMed Valuation or Volatility modules.
  
Check out the analysis of ResMed Correlation against competitors.

ResMed Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets7.2 B6.9 B3.9 B
Slightly volatile
Short and Long Term Debt Total448.1 M873.9 M749 M
Slightly volatile
Other Current Liabilities370 M352.4 M255 M
Slightly volatile
Total Current Liabilities956.2 M910.7 M550.7 M
Slightly volatile
Total Stockholder Equity5.1 B4.9 B2.5 B
Slightly volatile
Property Plant And Equipment Net734.1 M699.1 M471.9 M
Slightly volatile
Retained Earnings5.2 BB2.7 B
Slightly volatile
Accounts Payable249.6 M237.7 M116.5 M
Slightly volatile
Cash333.5 M238.4 M468.8 M
Slightly volatile
Non Current Assets Total4.7 B4.5 B2.3 B
Slightly volatile
Non Currrent Assets Other73.7 M114.2 M141.5 M
Slightly volatile
Cash And Short Term Investments338 M238.4 M469.1 M
Slightly volatile
Net Receivables879.1 M837.3 M483.9 M
Slightly volatile
Common Stock Shares Outstanding147.7 M147.6 M139 M
Slightly volatile
Liabilities And Stockholders Equity7.2 B6.9 B3.9 B
Slightly volatile
Non Current Liabilities Total1.2 B1.1 B839.4 M
Slightly volatile
Inventory863.4 M822.2 M409.7 M
Slightly volatile
Other Current Assets482.8 M459.8 M196.6 M
Slightly volatile
Total Liabilities2.1 BB1.4 B
Slightly volatile
Total Current Assets2.5 B2.4 B1.6 B
Slightly volatile
Short Term Debt68.6 M60.5 M86.1 M
Pretty Stable
Intangible Assets510.2 M485.9 M282.1 M
Slightly volatile
Property Plant And Equipment Gross1.5 B1.4 B571.4 M
Slightly volatile
Common Stock Total Equity417 K670.5 K536.9 K
Slightly volatile
Common Stock443.7 K676.2 K539.9 K
Slightly volatile
Other Assets315.5 M300.5 M144.8 M
Slightly volatile
Good WillB2.8 B1.4 B
Slightly volatile
Property Plant Equipment384.1 M765.7 M455.4 M
Slightly volatile
Other Liabilities380.6 M362.5 M150.9 M
Slightly volatile
Long Term Debt482.4 M697.3 M644.6 M
Slightly volatile
Current Deferred Revenue160.2 M152.6 M79.4 M
Slightly volatile
Retained Earnings Total Equity2.3 B3.3 B2.3 B
Slightly volatile
Long Term Debt Total737.7 M880.1 M646.1 M
Slightly volatile
Capital Surpluse1.5 B1.9 B1.4 B
Slightly volatile
Non Current Liabilities Other45.2 M42.3 M36.1 M
Slightly volatile
Deferred Long Term Asset Charges42.6 M52.3 M38.2 M
Slightly volatile
Short and Long Term Debt9.4 M9.9 M197.9 M
Slightly volatile
Long Term Investments42 M59.9 M40.3 M
Slightly volatile
Net Invested Capital4.3 B5.6 B3.6 B
Slightly volatile
Cash And Equivalents254.8 M246.3 M397.2 M
Slightly volatile
Net Working Capital1.1 B1.4 B1.1 B
Very volatile
Capital Stock641.7 K676.2 K588.7 K
Slightly volatile
Capital Lease Obligations156 M166.7 M131.6 M
Slightly volatile

ResMed Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization227 M216.2 M126.4 M
Slightly volatile
Total Revenue4.9 B4.7 B2.6 B
Slightly volatile
Gross Profit2.7 B2.6 B1.5 B
Slightly volatile
Other Operating Expenses3.5 B3.4 B1.9 B
Slightly volatile
Operating Income1.4 B1.3 B666.1 M
Slightly volatile
EBIT1.5 B1.4 B686 M
Slightly volatile
EBITDA1.7 B1.6 B812.3 M
Slightly volatile
Cost Of Revenue2.2 B2.1 B1.1 B
Slightly volatile
Total Operating Expenses1.4 B1.4 B815.4 M
Slightly volatile
Income Before Tax1.3 B1.3 B650.4 M
Slightly volatile
Net Income1.1 BB502.8 M
Slightly volatile
Income Tax Expense256 M243.8 M147.6 M
Slightly volatile
Selling General Administrative963 M917.1 M593.4 M
Slightly volatile
Research Development322.9 M307.5 M177.6 M
Slightly volatile
Net Income Applicable To Common Shares1.1 BB526.2 M
Slightly volatile
Selling And Marketing Expenses4.3 M6.3 M5.4 M
Very volatile
Net Income From Continuing Ops526.1 MB481.5 M
Slightly volatile
Tax Provision188.8 M243.8 M149.1 M
Slightly volatile
Interest Income31.4 M51.4 M29.4 M
Slightly volatile
Reconciled Depreciation187.5 M216.2 M148.3 M
Slightly volatile

ResMed Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Free Cash Flow1.4 B1.3 B508.1 M
Slightly volatile
Begin Period Cash Flow325.3 M227.9 M501.3 M
Slightly volatile
Depreciation227 M216.2 M132.5 M
Slightly volatile
Capital Expenditures66.9 M114.9 M84.6 M
Slightly volatile
Total Cash From Operating Activities1.5 B1.4 B596.2 M
Slightly volatile
Net Income1.1 BB502.8 M
Slightly volatile
End Period Cash Flow334.2 M238.4 M468.8 M
Slightly volatile
Stock Based Compensation40.4 M80.2 M48.8 M
Slightly volatile
Dividends Paid203 M282.3 M191.5 M
Slightly volatile
Issuance Of Capital Stock49.9 M53.1 M41.1 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio4.265.8666.0782
Slightly volatile
Dividend Yield0.01380.01030.0128
Slightly volatile
PTB Ratio4.775.65056.9578
Pretty Stable
Days Sales Outstanding81.9165.226572.5837
Slightly volatile
Book Value Per Share34.7433.08417.1372
Slightly volatile
Free Cash Flow Yield0.04910.04680.035
Slightly volatile
Operating Cash Flow Per Share10.019.5314.1224
Slightly volatile
Stock Based Compensation To Revenue0.0250.01710.0224
Slightly volatile
Capex To Depreciation0.50.53120.7636
Slightly volatile
PB Ratio4.775.65056.9578
Pretty Stable
EV To Sales4.226.00176.0958
Slightly volatile
Free Cash Flow Per Share9.198.74983.5115
Slightly volatile
ROIC0.10.19040.1488
Pretty Stable
Inventory Turnover2.142.52542.9353
Slightly volatile
Net Income Per Share7.296.94433.473
Slightly volatile
Days Of Inventory On Hand162145129
Slightly volatile
Payables Turnover5.818.73488.7333
Slightly volatile
Sales General And Administrative To Revenue0.340.30.2791
Pretty Stable
Research And Ddevelopement To Revenue0.07890.06560.0718
Slightly volatile
Capex To Revenue0.02330.02450.0369
Slightly volatile
Cash Per Share1.711.62133.2498
Slightly volatile
POCF Ratio24.0719.613931.3266
Slightly volatile
Interest Coverage50.6228.876643.1925
Slightly volatile
Payout Ratio0.440.27650.3994
Pretty Stable
Capex To Operating Cash Flow0.07790.0820.1818
Pretty Stable
PFCF Ratio41.6421.365142.2678
Slightly volatile
Days Payables Outstanding61.041.786745.2793
Slightly volatile
Income Quality0.961.37251.2121
Slightly volatile
ROE0.140.20990.1992
Pretty Stable
EV To Operating Cash Flow24.8920.067431.5878
Slightly volatile
PE Ratio27.9426.920134.6707
Slightly volatile
Return On Tangible Assets0.30.2880.2117
Slightly volatile
EV To Free Cash Flow20.7721.859141.1621
Slightly volatile
Earnings Yield0.03760.03710.0334
Slightly volatile
Intangibles To Total Assets0.510.48430.3552
Slightly volatile
Current Ratio4.02.5893.2768
Slightly volatile
Receivables Turnover3.985.59595.0601
Slightly volatile
Graham Number75.4971.897436.5178
Slightly volatile
Shareholders Equity Per Share34.7433.08417.1372
Slightly volatile
Debt To Equity0.220.15060.2973
Pretty Stable
Capex Per Share0.820.78120.6109
Slightly volatile
Revenue Per Share33.4631.868217.7667
Slightly volatile
Interest Debt Per Share5.565.29315.046
Slightly volatile
Debt To Assets0.130.10660.1769
Pretty Stable
Enterprise Value Over EBITDA14.817.571221.1175
Pretty Stable
Short Term Coverage Ratios37.8439.8334K
Slightly volatile
Price Earnings Ratio27.9426.920134.6707
Slightly volatile
Operating Cycle244210202
Slightly volatile
Price Book Value Ratio4.775.65056.9578
Pretty Stable
Days Of Payables Outstanding61.041.786745.2793
Slightly volatile
Dividend Payout Ratio0.440.27650.3994
Pretty Stable
Price To Operating Cash Flows Ratio24.0719.613931.3266
Slightly volatile
Price To Free Cash Flows Ratio41.6421.365142.2678
Slightly volatile
Pretax Profit Margin0.180.270.2371
Pretty Stable
Ebt Per Ebit1.130.95831.0552
Slightly volatile
Operating Profit Margin0.160.28170.2322
Slightly volatile
Effective Tax Rate0.320.19280.2437
Very volatile
Company Equity Multiplier1.221.41291.5758
Very volatile
Long Term Debt To Capitalization0.140.12540.1935
Pretty Stable
Total Debt To Capitalization0.150.13090.213
Pretty Stable
Return On Capital Employed0.140.22140.1924
Very volatile
Debt Equity Ratio0.220.15060.2973
Pretty Stable
Ebit Per Revenue0.160.28170.2322
Slightly volatile
Quick Ratio3.221.68612.5749
Slightly volatile
Dividend Paid And Capex Coverage Ratio3.73.52812.4823
Pretty Stable
Net Income Per E B T0.570.80720.749
Pretty Stable
Cash Ratio0.250.26171.202
Slightly volatile
Cash Conversion Cycle133168153
Slightly volatile
Operating Cash Flow Sales Ratio0.150.29910.2173
Pretty Stable
Days Of Inventory Outstanding162145129
Slightly volatile
Days Of Sales Outstanding81.9165.226572.5837
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.960.9180.8207
Pretty Stable
Cash Flow Coverage Ratios1.871.9131.2191
Slightly volatile
Price To Book Ratio4.775.65056.9578
Pretty Stable
Fixed Asset Turnover5.926.70155.9006
Very volatile
Capital Expenditure Coverage Ratio12.8112.20016.57
Slightly volatile
Price Cash Flow Ratio24.0719.613931.3266
Slightly volatile
Enterprise Value Multiple14.817.571221.1175
Pretty Stable
Debt Ratio0.130.10660.1769
Pretty Stable
Cash Flow To Debt Ratio1.871.9131.2191
Slightly volatile
Price Sales Ratio4.265.8666.0782
Slightly volatile
Return On Assets0.0960.14860.1263
Pretty Stable
Asset Turnover0.80.68180.7281
Slightly volatile
Net Profit Margin0.130.21790.1806
Very volatile
Gross Profit Margin0.670.55680.5949
Slightly volatile
Price Fair Value4.775.65056.9578
Pretty Stable
Return On Equity0.140.20990.1992
Pretty Stable

ResMed Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap461.4 M439.5 M453.1 M
Slightly volatile
Enterprise Value451 M429.5 M442.6 M
Slightly volatile

ResMed Fundamental Market Drivers

Forward Price Earnings26.6667
Cash And Short Term Investments238.4 M

ResMed Upcoming Events

25th of April 2024
Upcoming Quarterly Report
View
1st of August 2024
Next Financial Report
View
31st of March 2024
Next Fiscal Quarter End
View
1st of August 2024
Next Fiscal Year End
View
31st of December 2023
Last Quarter Report
View
30th of June 2023
Last Financial Announcement
View

About ResMed Financial Statements

ResMed stakeholders use historical fundamental indicators, such as ResMed's revenue or net income, to determine how well the company is positioned to perform in the future. Although ResMed investors may analyze each financial statement separately, they are all interrelated. For example, changes in ResMed's assets and liabilities are reflected in the revenues and expenses on ResMed's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in ResMed Inc. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue152.6 M160.2 M
Total Revenue4.7 B4.9 B
Cost Of Revenue2.1 B2.2 B
Stock Based Compensation To Revenue 0.02  0.03 
Sales General And Administrative To Revenue 0.30  0.34 
Research And Ddevelopement To Revenue 0.07  0.08 
Capex To Revenue 0.02  0.02 
Revenue Per Share 31.87  33.46 
Ebit Per Revenue 0.28  0.16 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether ResMed Inc is a strong investment it is important to analyze ResMed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ResMed's future performance. For an informed investment choice regarding ResMed Stock, refer to the following important reports:
Check out the analysis of ResMed Correlation against competitors.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ResMed. If investors know ResMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ResMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.416
Dividend Share
1.97
Earnings Share
7.53
Revenue Per Share
32.711
Quarterly Revenue Growth
0.111
The market value of ResMed Inc is measured differently than its book value, which is the value of ResMed that is recorded on the company's balance sheet. Investors also form their own opinion of ResMed's value that differs from its market value or its book value, called intrinsic value, which is ResMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ResMed's market value can be influenced by many factors that don't directly affect ResMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ResMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if ResMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ResMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.